Pancreatic Islet Transplantation

Pancreatic islet transplantation is a promising therapeutic approach for individuals with type 1 diabetes, particularly those who experience severe hypoglycemic episodes or have difficulty managing their blood glucose levels. In this procedure, clusters of insulin-producing cells, known as islets, are isolated from a donor pancreas and transplanted into the recipient's liver. Successful transplantation can restore insulin production and significantly improve metabolic control, reducing the need for exogenous insulin. However, challenges such as the shortage of suitable donor organs and the risk of transplant rejection necessitate lifelong immunosuppressive therapy. While not a cure, pancreatic islet transplantation offers a potential pathway toward better quality of life for patients with diabetes, highlighting the need for ongoing research to enhance islet survival and transplantation success rates.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp